AI at Nottingham

People 

Image of Cameron Alexander

Cameron Alexander

Professor of Polymer Therapeutics, Director of Research, Faculty of Science

Contact

Biography

Cameron Alexander is Professor of Polymer Therapeutics and a Fellow of the Royal Society of Chemistry. Following BSc and PhD degrees in Chemistry at the University of Durham, UK, he was a Post-Doctoral Research Fellow at the Melville Laboratory for Polymer Synthesis, University of Cambridge. Cameron has held many external roles, including elected membership of the EPSRC Science Engineering and Technology Board (SETB) from 2019-2022, and as Chair of the EPSRC Strategic Advisory Team from 2016-2019.

Cameron was awarded the Royal Society of Chemistry /Society of the Chemical Industry Macro Group UK Prize and Medal in 2014 for contributions to polymer science. He is currently the recipient of the Royal Society of Chemistry Interdisciplinary Prize and Medal 2025 for research at the interface of chemistry, pharmaceutical science and medicine..

Expertise Summary

We aim to develop materials which can improve the delivery of small molecule drugs, genes and vaccine components to target sites in the body, to enhance therapeutic efficacy and reduce side-effects. The main focus is on polymer therapeutics, for which we are developing a range of synthetic, natural and hybrid materials to transport drugs, genes and cells safely and efficiently to disease locations. We are currently working on polymer formulations for cancer medicines, anti-infectives and RNA vaccines in collaboration with groups from all over the world. Alumni from the group hold faculty posts at University College London, Sheffield, East Anglia, King's College London, Federico II (Napoli), Paris Est, Shenyang Pharmaceutical University (China), University College Dublin and senior research posts in Abzema, Achilles Therapeutics, AstraZeneca, Baxter Pharmaceuticals (China), Catalent, Cytrx, Exactmer, GSK, Lonza DPS, Malvern Instruments, MIP Diagnostics, Quotient, Revolymer, Samsung, Sanofi, Sygnature, Synthomer, UCB Pharma and ViaNautis.

Teaching Summary

Teaching

MPharm. Medicines Pathway (Convenor) - Clinical Trials and Case Studies of Accelerated Trials (Year 2); Cancers module - Cancer Pharmaceutics (Year 3)

Pharmaceutical Sciences MSci. Pharmaceutical Biotechnology - Protein and Vaccine Formulations.(Year 2). Biologics - Viral and Non-viral gene delivery, Advanced Nucleic Acid Formulations (Year 3)

Applied Biomolecular Technology MSc - Contributor to drug delivery / pharmaceutics modules,

Research Summary

Key research foci include smart materials (Biomater. Sci. 2025, Biomater. Sci. 2023, Nanoscale 2021, Nature Mater 2014), drug and gene delivery (Br. J. Cancer 2024, J. Control Release 2023, Biomater.… read more

Selected Publications

University of Nottingham
University Park
Nottingham, NG7 2RD

telephone: +44 (0) 115 951 5151
fax: +44 (0) 115 951 3666
email: Contact us